You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Johnson and Johnson
Colorcon
Dow
Mallinckrodt

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SPINOSAD

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for spinosad

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00311779 A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis Completed ParaPRO LLC Phase 2 2006-03-01 The primary objective of the study is to determine the safety and efficacy of different strengths of Spinosad topical creme, as compared to a vehicle control, in subjects who have been infested with at least a mild case of Pediculosis capitis (head lice).
NCT00410709 A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age Completed ParaPRO LLC Phase 1 2006-12-01 This is an open label, single center, single dose PK study of NatrOVA Creme Rinse (1%), an investigational treatment for head lice and nits, in normal, healthy infants.
NCT00545168 Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice Completed ParaPRO LLC Phase 3 2007-09-01 A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (Head lice).
NCT00545753 Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice Completed ParaPRO LLC Phase 3 2007-09-01 A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (human head lice).
NCT00858481 A Pilot Dose Ranging Study of Spinosad Creme Rinse Completed ParaPRO LLC Phase 2 2005-09-01 A pilot dose ranging study to evaluate the safety and efficacy of different strengths of Spinosad Creme versus a vehicle control.
NCT01660321 Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation Completed ParaPRO LLC Phase 4 2011-09-01 A pharmacokinetic and tolerance study of Natroba (spinosad) Topical Suspension, 0.9% in pediatric subjects 6 months to 4 years of age with an active head lice infestation.
NCT02485704 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Suspended Accelovance Phase 3 2015-06-01 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the the safety and efficacy of of open-label Natroba for the clinical cure of subjects who demonstrated treatment failure after the blinded first application of spinosad or placebo.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for spinosad

Condition Name

Condition Name for spinosad
Intervention Trials
Scabies 2
Pediculosis Capitis (Head Lice) 2
Pediculosis 2
Pediculus Capitis Infestation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for spinosad
Intervention Trials
Lice Infestations 6
Parasitic Diseases 2
Scabies 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for spinosad

Trials by Country

Trials by Country for spinosad
Location Trials
United States 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for spinosad
Location Trials
Florida 6
California 3
Texas 2
Ohio 2
Arizona 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for spinosad

Clinical Trial Phase

Clinical Trial Phase for spinosad
Clinical Trial Phase Trials
Phase 4 1
Phase 3 4
Phase 2 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for spinosad
Clinical Trial Phase Trials
Completed 6
Suspended 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for spinosad

Sponsor Name

Sponsor Name for spinosad
Sponsor Trials
ParaPRO LLC 8
Accelovance 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for spinosad
Sponsor Trials
Industry 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Medtronic
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.